When new drugs come to market, they are either a better version of an established class, a new delivery method, or a whole new class with a steep learning curve. This week, in our two lead articles, we look at some new compounds and some new delivery systems that could actually revolutionize the care of diabetes for the next 50 years. The great news is that some of them may be here sooner than you think.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief